Results 171 to 180 of about 16,224 (212)

Progressive Supranuclear Palsy

The Neurologist, 2008
Progressive supranuclear palsy (PSP) is the second most common cause of parkinsonism after Parkinson's disease (PD). The classic syndrome of PSP is widely recognized by neurologists as a combination of down gaze palsy with progressive rigidity and imbalance leading to falls.
Michael, Lubarsky, Jorge L, Juncos
openaire   +2 more sources

Pneumoencephalography of Progressive Supranuclear Palsy

Radiology, 1974
Pneumoencephalograms of six patients with progressive supranuclear palsy were analyzed with special attention to the midbrain and were compared to studies of patients with Parkinson's disease and those with various cerebellar degenerative diseases. Severe atrophy of the midbrain tegmentum and atrophy of the superior colliculi relative to the inferior ...
J R, Bentson, J C, Keesey
openaire   +2 more sources

The Differentiation of Progressive Supranuclear Palsy

Neurodegenerative Disease Management, 2015
The Department of Aged Care, St George & Calvary Hospitals, 3 Chapel Street, Kogarah NSW 2217, Sydney, Australia Neuroscience Research Australia & University of New South Wales, Sydney, Australia *Author for correspondence: Tel.: +612 9113 2183; Fax: +612 9113 3979; Nicholas.Cordato@sesiahs.health.nsw.gov ...
Nicholas J, Cordato, Glenda M, Halliday
openaire   +2 more sources

Progressive Supranuclear Palsy

Archives of Neurology, 1973
Thirty-one electroencephalograms from 12 patients with progressive supranuclear palsy (PSP) were examined. Four patients had initially abnormal records. Five other patients had initially normal records, but all developed abnormalities during the follow-up period. Three of 12 patients had normal records; each of them had only one record taken.
P C, Su, E S, Goldensohn
openaire   +2 more sources

Progressive supranuclear Palsy

Archiv f�r Psychiatrie und Nervenkrankheiten, 1971
Es wird uber eine Beobachtung von „progressive supranuclear palsy“ berichtet, bei der die Erkrankung etwa mit 12 Jahren begann, uber 23 Jahre hin langsam progressiv verlief und die klinisch im wesentlichen durch eine parkinsonistische Symptomatik ausgezeichnet war. Anatomisch fand sich neben einer schweren Degeneration der S.
openaire   +2 more sources

PROGRESSIVE SUPRANUCLEAR PALSY

Medical Clinics of North America, 1999
Richardson observed an unusual clinical syndrome in the 1950s, which he later designated progressive supranuclear palsy (PSP). Over the past 25 years, although knowledge of this disorder has gradually improved, its cause is still unknown, pathogenesis is unclear, and there is still no definitive treatment for this disorder.
openaire   +2 more sources

Pain in Progressive Supranuclear Palsy

Clinical Neuropharmacology, 2009
We describe a patient with progressive supranuclear palsy who presented with a major complaint of neck pain. The pain was alleviated when given lidocaine intravenously. Response was maintained for an extended period. Lidocaine should be considered in pain relief of dystonia to improve quality of life.
Ilana, Schlesinger, Ana, Klesier, David, Yarnitsky   +2 more
openaire   +2 more sources

Pramipexole in progressive supranuclear palsy

Neurology, 1999
Progressive supranuclear palsy (PSP) is a progressive neurodegenerative disorder with no effective treatment. Dopaminergic agents occasionally produce transient symptomatic improvement. The authors report the results of pramipexole treatment (4.5 mg daily) in six patients with PSP (average disease duration, 4.4 years).
W J, Weiner, A, Minagar, L M, Shulman
openaire   +2 more sources

Vascular progressive supranuclear palsy

1994
Progressive supranuclear palsy (PSP) is a neurologic syndrome of unknown cause. This idiopathic type of PSP is usually associated with characteristic clinical and pathological features.To assess evidence of cerebrovascular disease in a population of patients with clinically defined PSP, and to compare clinical and neuroimaging features in vascular ...
J, Winikates, J, Jankovic
openaire   +2 more sources

Hyposmia in progressive supranuclear palsy

Movement Disorders, 2010
AbstractPrevious studies suggested that olfaction is normal in progressive supranuclear palsy (PSP). We applied the University of Pennsylvania Smell Identification Test (UPSIT) to 36 patients with PSP who scored more than 18 on the Mini Mental State Examination (MMSE), 140 patients with nondemented Parkinson's disease (PD) and 126 controls.
Silveira-Moriyama L, Hughes G, Church A, Ayling H, Williams DR, Petrie A, Holton J, Revesz T, Kingsbury A, Morris HR, Burn DJ, Lees AJ   +11 more
openaire   +3 more sources